Enhanced cell surface expression, immunogenicity and genetic stability resulting from a spontaneous truncation of HIV Env expressed by a recombinant MVA
- 28 November 2007
- Vol. 372 (2) , 260-272
- https://doi.org/10.1016/j.virol.2007.10.033
Abstract
No abstract availableKeywords
This publication has 81 references indexed in Scilit:
- Avidity of CD8 T cells sharpens immunodominanceInternational Immunology, 2007
- A Conserved Dileucine Motif Mediates Clathrin and AP-2–dependent Endocytosis of the HIV-1 Envelope ProteinMolecular Biology of the Cell, 2007
- Phase I clinical trial safety of DNA- and modified virus Ankara-vectored human immunodeficiency virus type 1 (HIV-1) vaccines administered alone and in a prime-boost regime to healthy HIV-1-uninfected volunteersVaccine, 2006
- Different Patterns of Immune Responses but Similar Control of a Simian-Human Immunodeficiency Virus 89.6P Mucosal Challenge by Modified Vaccinia Virus Ankara (MVA) and DNA/MVA VaccinesJournal of Virology, 2002
- Effect of vaccination with recombinant modified vaccinia virus Ankara expressing structural and regulatory genes of SIVmacJ5 on the kinetics of SIV replication in cynomolgus monkeysJournal of Medical Primatology, 2001
- Sexual Transmission and Propagation of SIV and HIV in Resting and Activated CD4 + T CellsScience, 1999
- Immunogenicity of Full Length and Truncated SIV Envelope ProteinsViral Immunology, 1999
- Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal modelVaccine, 1996
- A Broadly Neutralizing Human Monoclonal Antibody against gp41 of Human Immunodeficiency Virus Type 1AIDS Research and Human Retroviruses, 1994
- SIV adaption to human cellsNature, 1989